Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Scynexis’s Brexafemme Label-Expansion Plan Focused On Invasive Candidiasis
Dec 06 2021
•
By
Joseph Haas
Scynexis wants to position Brexafemme to fight fungal infections with high mortality
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Strategy
More from Business